Board of Directors

Tethis S.p.A.

Mario Zanone Poma

CEO and President

Mario Zanone Poma serves currently as Enoi Board Member (Energy Company), President of CEI  (Compagnia Energetica Italiana), Chaiman of Tethis and Wise, Co-Founder of Tecnalogic. During his career he has been CEO and Chairman of large companies such as  Kalle Infotec (Hoechst Group), Telepiù (the first Pay TV in Italy),  Commisioner of Fondazione Cariplo and President  of Mediocredito Italiano. He has been also Co-Founder and first President of NED Community (Indipendent Board Members Association), President of Governance Consulting, Chairman of Advisory Board of Cap-Geminy Ernest & Young and President of Italy-China Chamber of Commerce. Mario holds a degree in Economics.

Guido Guidi

Director

Guido Guidi serves as chairman and co-founder of AURORA TT plus senior consultant and board member of different pharmaceuticals and diagnostics companies. Guido has twenty-six years of work experience inside Novartis becoming first Head of BU Oncology Southern Europe then Onco Region Europe Head and most recently Head of Pharma Region Europe. Guido covered different medical positions at GSK, Roussel-UCLAF and Sandoz. He was member of EFPIA (European Federation of Pharmaceutical Industries and Associations). Guido contributed to about 30 publications, mainly focusing on clinical research management. Guido holds a degree in Medicine and Specialization in immunology and rheumatology from University of Milan.

Alvise Bonivento

Director

Alvise Bonivento is currently Investment Director at Atlante Ventures and serves as board member/observer in several portfolio companies. During his professional career he worked as researcher in Silicon Valley and at the Electrical Engineering and Computer Science Department of University of California at Berkeley. He has been a technology consultant for several Italian groups in the development of industrial wireless technologies. He later worked at McKinsey & Co before becoming a venture capital professional in 2009 . Alvise holds a degree in Telecommunication Engineering at the University of Padua and a PhD in Electrical Engineering and Computer Science from the University of California at Berkeley.

Marco Bucci

Director

Marco has a long international managerial experience, as VP for Eastman Kodak Co. (NY), VP for SGS (Geneva), President at Carestream Health (NY), CEO at Liguria Digitale (Genoa). He has left the position as CEO of Tethis having been elected Mayor of Genoa.
Marco received a Laurea, Summa cum Laude, in Chemistry and Pharmaceutical Technology and a Laurea, Summa cum Laude, in Pharmacy from the University of Genoa, Italy. 

Tethis Labs Inc.

Marco Rissoglio

Chairman

Marco Dario Rissoglio serves as Chairman at Tethis INC and Chief Operating of Tethis S.p.A. since 2016, leading the company operations, marketing and sales.  Marco has 25 years of experience in scientific analytical and diagnostic instrumentation, laboratory chemicals and pharmaceutical (API)  within life sciences, most recently as  Chief Commercial Officer for Carlo Erba Reagents (Ex Montedison).  Previously he lead sales and marketing roles with Kontron Instruments (Roche group), Applied Biosystems. Marco holds a degree in Business Administration from University of Turin.

Erik Sandvick

CEO

Erik Sandvick serves as Chief Executive Officer at Tethis Labs Incorporated, USA. He has worked extensively in the medical device and biotech industry with over 18 years of leadership experience.  Erik holds a degree in business administration and management from Oklahoma State University and studied international business and European community law at Regents University London.

Scientific advisory board

Paolo Milani

Chairman

Paolo Milani at the University of Milano serves as Full Professor at the Department of Physics and Director of the Interdisciplinary Centre for Nanostructured Materials and Interfaces .Paolo is member of the scientific board of the Leonardo da Vinci National Museum and of the Mentor’s Club of PoliHub Start Up District & Incubator. He is the Coordinator of the PhD School in Medical Nanotechnology. Paolo has published more than 250 papers on refereed journals and he is a member of different editorial boards as KONA Powder. His research focuses on cluster-assembled nanostructured materials for sensors, stretchable electronics, biomedicine, soft robotics. Paolo holds a degree in Physics from the University of Pavia and a PhD (Docteur ès Sciences) from the Ecole Polytechnique Federale of Lausanne.

Guido Guidi

Guido Guidi serves as chairman and co-founder of AURORA TT plus senior consultant and board member of different pharmaceuticals and diagnostics companies. Guido has twenty-six years of work experience inside Novartis becoming first Head of BU Oncology Southern Europe then Onco Region Europe Head and most recently Head of Pharma Region Europe. Guido covered different medical positions at GSK, Roussel-UCLAF and Sandoz. He was member of EFPIA (European Federation of Pharmaceutical Industries and Associations). Guido contributed to about 30 publications, mainly focusing on clinical research management. Guido holds a degree in Medicine and Specialization in immunology and rheumatology from University of Milan.

Mariano Rocchi

Mariano Rocchi is a biologist, actually serves as full Professor of Genetics at the University of Bari and President of the Scientific Programme Committee of the European Cytogenetics Association. During his career he worked at Burlo Garofalo Institute, Genova Gaslini Institute and Wayne State University.
Mariano was invited speaker in several countries and author of more than 360 publications in international journals, including Nature, Science, Nature Genetics and PNAS. His relevant experiences covered molecular cytogenetics characterization of tumors, evolution of genomes and centromere repositioning. He collaborated in the sequencing and analysis of the genomes of chimpanzee, orangutan, and macaque.

Major investors